Snowball logo
logo
0030_logo

Bukwang Pharm

003000 β€’ KO
β‚©4,410.00β‚©0.00Β  (0%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
182,491.2190,909.4125,928.2160,086.9200,714.2200,683.8
COGS
106,733.2111,480.678,854.785,743.7108,804.7110,675.7
Gross Profit
75,75879,428.847,073.574,343.291,909.590,008.1
Operating Expenses & Income
Operating Income
5,621.9(230.6)(37,496.8)1,617.714,163.812,253.9
Total Operating Expenses
176,869.3191,140163,425158,469.2186,550.4188,429.9
R&D Expenses
22,464.624,274.434,551.223,430.619,401.419,512.5
Selling General & Admin Expenses
13,493.919,822.122,105.616,837.424,805.439,565.9
Earnings from Continuing Operations
Interest Expense
(1,408.3)(1,760.3)(3,807.6)(6,489.6)(3,895)-
Interest Income
264.31,4403,079.84,418.74,710.6-
Income Tax Expense
6,584.1-----
Net Income
Net Income
(916.6)(2,474.9)(31,329.7)(2,641.3)12,557.613,804.1
Supplemental
EBIT
5,621.9-----
EBITDA
10,038.45,844----
In millions of KRW, except % and values per 1 share